These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 39345022

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu-PSMA Therapy.
    Jafari E, Manafi-Farid R, Ahmadzadehfar H, Salek F, Jokar N, Keshavarz A, Divband G, Dadgar H, Zohrabi F, Assadi M.
    Nuklearmedizin; 2024 Dec; 63(6):347-358. PubMed ID: 39227023
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68 Ga-HBED-CC-Exendin-4 in Localizing Insulinoma : A Head-to-Head Comparison to 68 Ga-NOTA-Exendin-4.
    Li L, Wang G, Wang J, Ma H, Chen J, Wang R, Pan Q, Hong H, Jin W, Kung HF, Zhu L, Luo Y, Zhu Z.
    Clin Nucl Med; 2025 Jan 01; 50(1):38-43. PubMed ID: 39499011
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Use of Multiparametric and Biparametric Magnetic Resonance Imaging in Bladder Cancer Staging: Prospective Observational Study and Analysis of Radiologist Learning Curve.
    Piramide F, Sica M, Fondello G, Mesterca G, Ferrando L, Ziani N, Ortenzi M, Grosso G, Desana B, Frattoni P, De Cillis S, Piana A, Amparore D, Checcucci E, Fiori C, Cirillo S, Porpiglia F, Manfredi M.
    J Clin Med; 2024 Nov 18; 13(22):. PubMed ID: 39598099
    [Abstract] [Full Text] [Related]

  • 27. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H, Kenny RP, Robinson T, Stoniute A, O'Keefe H, Still M, Thornton C, Pearson F, Beyer F, Meader N.
    Health Technol Assess; 2024 Oct 18; 28(75):1-75. PubMed ID: 39487741
    [Abstract] [Full Text] [Related]

  • 28. Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?
    Belue MJ, Blake Z, Yilmaz EC, Lin Y, Harmon SA, Nemirovsky DR, Enders JJ, Kenigsberg AP, Mendhiratta N, Rothberg M, Toubaji A, Merino MJ, Gurram S, Wood BJ, Choyke PL, Turkbey B, Pinto PA.
    Prostate; 2023 Dec 18; 83(16):1519-1528. PubMed ID: 37622756
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The quantitative impact of prostate-specific membrane antigen (PSMA) PET/CT staging in newly diagnosed metastatic prostate cancer and treatment-decision implications.
    Abdel-Aty H, Hujairi N, Murray I, Yogeswaran Y, van As N, James N.
    BJR Open; 2024 Jan 18; 6(1):tzae040. PubMed ID: 39606160
    [Abstract] [Full Text] [Related]

  • 32. Is Quantitative Radiographic Measurement of Acetabular Version Reliable in Anteverted and Retroverted Hips?
    Yonga Ö, Güven M, Akman B, Yüksel K.
    Clin Orthop Relat Res; 2024 Dec 01; 482(12):2136-2144. PubMed ID: 38996337
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
    Giunta EF, Caroli P, Scarpi E, Altavilla A, Rossetti V, Marini I, Celli M, Casadei C, Lolli C, Schepisi G, Bleve S, Brighi N, Cursano MC, Paganelli G, Matteucci F, De Giorgi U.
    Eur J Nucl Med Mol Imaging; 2024 Dec 01; 52(1):326-334. PubMed ID: 39207484
    [Abstract] [Full Text] [Related]

  • 35. Contribution of an Artificial Intelligence Tool in the Detection of Incidental Pulmonary Embolism on Oncology Assessment Scans.
    Ammari S, Camez AO, Ayobi A, Quenet S, Zemmouri A, Mniai EM, Chaibi Y, Franciosini A, Clavel L, Bidault F, Muller S, Lassau N, Balleyguier C, Assi T.
    Life (Basel); 2024 Oct 22; 14(11):. PubMed ID: 39598146
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
    Yilmaz B, Turkay R, Colakoglu Y, Baytekin HF, Ergul N, Sahin S, Tugcu V, Inci E, Tasci AI, Cermik TF.
    Prostate; 2019 Jun 22; 79(9):1007-1017. PubMed ID: 31012125
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparative Diagnostic Value of 18F-FDG-PET-CT and Intraoperative Examination in Cervical Cancer Staging.
    Malenković G, Malenković J, Tomić S, Šljivo A, Gavrankapetanović-Smailbegović F, Tomić S.
    Medicina (Kaunas); 2024 Oct 26; 60(11):. PubMed ID: 39596943
    [Abstract] [Full Text] [Related]

  • 40. Comparison between pelvic MRI, CT, and PET/CT in baseline staging and radiation planning of anal squamous cell carcinoma.
    Horvat N, Jayaprakasam VS, Crane CH, Zheng J, Gangai N, Romesser PB, Golia Pernicka JS, Capanu M, Gollub MJ.
    Abdom Radiol (NY); 2024 May 26; 49(5):1351-1362. PubMed ID: 38456896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.